Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D09EEV
|
|||
Former ID |
DIB010577
|
|||
Drug Name |
Declopramide
|
|||
Synonyms |
IBD therapy, Active Biotech; Inflammatory bowel disease therapy, Active Biotech; OXi-104; IMO-B project, Active Biotech; 3-CPA; 3-chloroprocainamide
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Inflammatory bowel disease [ICD-11: DD72; ICD-10: K50-K52] | Discontinued in Phase 2 | [1] | |
Company |
OXiGENE Inc
|
|||
Structure |
Download2D MOL |
|||
Formula |
C13H20ClN3O
|
|||
Canonical SMILES |
CCN(CC)CCNC(=O)C1=CC(=C(C=C1)N)Cl
|
|||
InChI |
1S/C13H20ClN3O/c1-3-17(4-2)8-7-16-13(18)10-5-6-12(15)11(14)9-10/h5-6,9H,3-4,7-8,15H2,1-2H3,(H,16,18)
|
|||
InChIKey |
YEYAKZXEBSVURO-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 891-60-1
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800007055) | |||
REF 2 | Pharmacokinetics and central nervous system toxicity of declopramide (3-chloroprocainamide) in rats and mice. Anticancer Drugs. 1999 Jan;10(1):79-88. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.